The Europe Demineralized Bone Matrix Market would witness market growth of 5.2% CAGR during the forecast period (2023-2030).
The Germany market dominated the Europe Demineralized Bone Matrix Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $114.8 million by 2030. The UK market is exhibiting a CAGR of 4.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 6.1% during (2023 - 2030).
DBM is extensively used in spinal fusion surgeries to promote bone growth and facilitate the fusion of spinal vertebrae. Surgeons utilize DBM as a grafting material to fill bone voids, augment fusion sites, and enhance the stability of spinal implants. DBM’s osteoinductive properties stimulate the formation of new bone tissue, aiding in the fusion process and promoting long-term spinal stability. In orthopaedic trauma surgery, DBM plays a vital role in the repair of fractures and non-unions.
DBM grafts are applied to fracture sites to accelerate bone healing, enhance fracture union, and restore skeletal integrity. By providing a scaffold for new bone formation, DBM facilitates the regeneration of damaged bone tissue and promotes optimal functional recovery in patients with traumatic injuries. Moreover, DBM is utilized in joint reconstruction procedures to address osteoarthritis, avascular necrosis, and joint degeneration.
The higher prevalence of work-related musculoskeletal disorders may lead to an expansion of the orthopaedic surgery industry in the UK. According to the “Work-related musculoskeletal disorders statistics in Great Britain” report published in 2023, in 2022/23, there were an estimated 473,000 workers suffering from work-related musculoskeletal disorders. This represents 1,400 per 100,000 workers and resulted in an estimated 6.6 million working days lost. Therefore, the increasing prevalence of the musculoskeletal disorders in the region is propelling the growth of the market.
Based on End-use, the market is segmented into Outpatient Facilities, and Hospitals. Based on Product Type, the market is segmented into Putty, Fiber, Sponge, Paste, Gel, and Others. Based on Application, the market is segmented into Spinal Fusion, Dental, Joint Reconstruction, Hand, Foot, & Ankle, Long Bone, and Craniomaxillofacial. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Demineralized Bone Matrix Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $114.8 million by 2030. The UK market is exhibiting a CAGR of 4.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 6.1% during (2023 - 2030).
DBM is extensively used in spinal fusion surgeries to promote bone growth and facilitate the fusion of spinal vertebrae. Surgeons utilize DBM as a grafting material to fill bone voids, augment fusion sites, and enhance the stability of spinal implants. DBM’s osteoinductive properties stimulate the formation of new bone tissue, aiding in the fusion process and promoting long-term spinal stability. In orthopaedic trauma surgery, DBM plays a vital role in the repair of fractures and non-unions.
DBM grafts are applied to fracture sites to accelerate bone healing, enhance fracture union, and restore skeletal integrity. By providing a scaffold for new bone formation, DBM facilitates the regeneration of damaged bone tissue and promotes optimal functional recovery in patients with traumatic injuries. Moreover, DBM is utilized in joint reconstruction procedures to address osteoarthritis, avascular necrosis, and joint degeneration.
The higher prevalence of work-related musculoskeletal disorders may lead to an expansion of the orthopaedic surgery industry in the UK. According to the “Work-related musculoskeletal disorders statistics in Great Britain” report published in 2023, in 2022/23, there were an estimated 473,000 workers suffering from work-related musculoskeletal disorders. This represents 1,400 per 100,000 workers and resulted in an estimated 6.6 million working days lost. Therefore, the increasing prevalence of the musculoskeletal disorders in the region is propelling the growth of the market.
Based on End-use, the market is segmented into Outpatient Facilities, and Hospitals. Based on Product Type, the market is segmented into Putty, Fiber, Sponge, Paste, Gel, and Others. Based on Application, the market is segmented into Spinal Fusion, Dental, Joint Reconstruction, Hand, Foot, & Ankle, Long Bone, and Craniomaxillofacial. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Zimmer Biomet Holdings, Inc.
- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Arthrex, Inc.
- Globus Medical, Inc.
- Berkeley Advanced Biomaterials
- Xtant Medical Holdings, Inc.
- Orthofix Medical Inc.
- Institut Straumann AG
Market Report Segmentation
By End-use- Outpatient Facilities
- Hospitals
- Putty
- Fiber
- Sponge
- Paste
- Gel
- Others
- Government
- Energy
- Defense
- Agriculture & Forestry
- Media & Entertainment
- Civil Engineering & Archaeology
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Demineralized Bone Matrix Market by End-use
Chapter 5. Europe Demineralized Bone Matrix Market by Product Type
Chapter 6. Europe Demineralized Bone Matrix Market by Application
Chapter 7. Europe Demineralized Bone Matrix Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Zimmer Biomet Holdings, Inc.
- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Arthrex, Inc.
- Globus Medical, Inc.
- Berkeley Advanced Biomaterials
- Xtant Medical Holdings, Inc.
- Orthofix Medical Inc.
- Institut Straumann AG
Methodology
LOADING...
